- Home
- VRDN vs FOR Comparison
VRDN vs FOR Comparison
Compare VRDN & FOR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VRDN
- FOR
- Stock Information
- Founded
- VRDN 2006
- FOR 2005
- Country
- VRDN United States
- FOR United States
- Employees
- VRDN N/A
- FOR N/A
- Industry
- VRDN Medical Specialities
- FOR Real Estate
- Sector
- VRDN Health Care
- FOR Finance
- Exchange
- VRDN Nasdaq
- FOR Nasdaq
- Market Cap
- VRDN 1.6B
- FOR 1.4B
- IPO Year
- VRDN N/A
- FOR 2007
- Fundamental
- Price
- VRDN $20.78
- FOR $25.99
- Analyst Decision
- VRDN Strong Buy
- FOR Strong Buy
- Analyst Count
- VRDN 10
- FOR 4
- Target Price
- VRDN $36.33
- FOR $30.25
- AVG Volume (30 Days)
- VRDN 718.1K
- FOR 136.2K
- Earning Date
- VRDN 11-11-2025
- FOR 10-28-2025
- Dividend Yield
- VRDN N/A
- FOR N/A
- EPS Growth
- VRDN N/A
- FOR N/A
- EPS
- VRDN N/A
- FOR 3.19
- Revenue
- VRDN $305,000.00
- FOR $1,543,300,000.00
- Revenue This Year
- VRDN N/A
- FOR $3.62
- Revenue Next Year
- VRDN $34,044.63
- FOR $7.99
- P/E Ratio
- VRDN N/A
- FOR $8.19
- Revenue Growth
- VRDN 5.90
- FOR 2.35
- 52 Week Low
- VRDN $9.90
- FOR $18.00
- 52 Week High
- VRDN $27.20
- FOR $34.82
- Technical
- Relative Strength Index (RSI)
- VRDN 54.30
- FOR 47.20
- Support Level
- VRDN $20.69
- FOR $26.13
- Resistance Level
- VRDN $22.37
- FOR $27.36
- Average True Range (ATR)
- VRDN 0.97
- FOR 0.79
- MACD
- VRDN -0.06
- FOR -0.11
- Stochastic Oscillator
- VRDN 54.71
- FOR 54.10
About VRDN Viridian Therapeutics Inc.
Viridian Therapeutics Inc is a clinical-stage biopharmaceutical company that engages in developing multiple product candidates to treat patients who suffer from thyroid eye disease. Its product candidate includes Veligrotug (formerly known as VRDN-001) for intravenous (IV) and VRDN-003 for subcutaneous (SC) administration. Veligrotug is a differentiated humanized monoclonal antibody targeting IGF-1R intravenously administered for the treatment of thyroid eye disease (TED).
About FOR Forestar Group Inc
Forestar Group Inc is a residential lot development company with operations across the United States. The core business segment for the company is real estate which generates all of it's revenues. The firm fundamentally acquires entitled real estate and develops it into finished residential lots for sale to homebuilders with a strategic focus on asset turns and efficiency. Single-family residential communities account for the majority of their real estate projects. The company utilizes a lower-risk business model mainly by investing in short duration, phased development projects.